Page last updated: 2024-11-04

sarpogrelate and Coronary Vasospasm

sarpogrelate has been researched along with Coronary Vasospasm in 2 studies

sarpogrelate: structure given in first source

Coronary Vasospasm: Spasm of the large- or medium-sized coronary arteries.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, SR1
Choi, KH1
Song, YB1
Lee, JM1
Park, TK1
Yang, JH1
Hahn, JY1
Choi, JH1
Choi, SH1
Gwon, HC1
Miyata, K1
Shimokawa, H1
Higo, T1
Yamawaki, T1
Katsumata, N1
Kandabashi, T1
Tanaka, E1
Takamura, Y1
Yogo, K1
Egashira, K1
Takeshita, A1

Trials

1 trial available for sarpogrelate and Coronary Vasospasm

ArticleYear
Effect of sarpogrelate and high-dose statin on the reduction of coronary spasm in vasospastic angina: A two by two factorial, pilot randomized study.
    Clinical cardiology, 2019, Volume: 42, Issue:10

    Topics: Adult; Aged; Angina Pectoris; Coronary Angiography; Coronary Vasospasm; Dose-Response Relationship,

2019

Other Studies

1 other study available for sarpogrelate and Coronary Vasospasm

ArticleYear
Sarpogrelate, a selective 5-HT2A serotonergic receptor antagonist, inhibits serotonin-induced coronary artery spasm in a porcine model.
    Journal of cardiovascular pharmacology, 2000, Volume: 35, Issue:2

    Topics: Angiography; Animals; Base Sequence; Coronary Vasospasm; Dinoprost; Disease Models, Animal; Dose-Res

2000